Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

NCT04321070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Clindamycin Phosphate
DRUG: Clindamycin Phosphate RLD
DRUG: Placebos

Sponsor

Sun Pharmaceutical Industries, Inc.